ARCHIVES

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

This article is from The Cancer Letter archive.

Vol. 18 No. 24 | June 12, 1992

Download PDF Visit The Full Archive

Related Articles

Brothers Of Prostate Cancer Patients At Risk Of Diagnosis

August 27, 2010

Also In sudden policy change, NIH proposes one-year ban on consulting by employees.

October 1, 2004

CPT-11, Gemcitabine Increase Survival Of Pancreatic Cancer

March 29, 2002

PD-1 Checkpoint Inhibitor Opdivo First to Demonstrate Survival Benefit in Phase III

November 28, 2014

In Brief: Upton Says Delaney Clause Is Needed: CPSC Drops Effort To Set Policy On Carcinogens

May 4, 1979

Tempero, Johnson Take ASCO Offices

June 6, 2003